These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34940846)
61. The Impact of Cuthbertson DJ; Barriuso J; Lamarca A; Manoharan P; Westwood T; Jaffa M; Fenwick SW; Nuttall C; Lalloo F; Prachalias A; Pizanias M; Wieshmann H; McNamara MG; Hubner R; Srirajaskanthan R; Vivian G; Ramage J; Weickert MO; Pritchard DM; Vinjamuri S; Valle J; Yip VS Front Endocrinol (Lausanne); 2021; 12():654975. PubMed ID: 34163434 [TBL] [Abstract][Full Text] [Related]
62. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours. Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220 [TBL] [Abstract][Full Text] [Related]
73. Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of Lodge MA; Solnes LB; Chaudhry MA; Wahl RL Mol Imaging Biol; 2021 Oct; 23(5):766-774. PubMed ID: 33829361 [TBL] [Abstract][Full Text] [Related]
74. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT. Madrzak D; Mikołajczak R; Kamiński G Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886 [TBL] [Abstract][Full Text] [Related]
75. Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers. Weich A; Higuchi T; Bundschuh RA; Lapa C; Serfling SE; Rowe SP; Pomper MG; Herrmann K; Buck AK; Derlin T; Werner RA Mol Imaging Biol; 2022 Aug; 24(4):631-640. PubMed ID: 35233654 [TBL] [Abstract][Full Text] [Related]
76. Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium in 111 pentetreotide. Zalom ML; Waxman AD; Yu R; Lee J; Ih G; Wolin EM Endocr Pract; 2009; 15(6):521-7. PubMed ID: 19491080 [TBL] [Abstract][Full Text] [Related]